Pharma
Bristol Myers Squibb to appeal High Court ruling striking down patent on $12bn drug
Court recently invalidated the patent associated with Eliquis, the US pharma giants drug to reduce blood clots
Bristol Myers Squibb (BMS), the US pharma giant, has said it will appeal a ruling by the High Court to dismiss the patent on one of its biggest selling drugs.
The US pharma company, which has significant operations in Ireland, confirmed this week it will appeal the Irish High Court decision to invalidate the patent on its Eliquis drug, which is a blood thinner medicine used to treat blood clots and generated sales of $12 ...
